Physician profile
Benjamin Alan Melone
NPI 1487138970
$2,086.69
in general payments reported to CMS, 2019-2025
13 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.06 · 2022: $368 · 2023: $333 · 2024: $785 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,170.01 | 2023-2025 | Proclaim, Penta, Eterna |
| Si-Bone, INC. | $201.85 | 2022-2024 | |
| Boston Scientific Corporation | $170.61 | 2024-2025 | Intracept |
| Medtronic, INC. | $146.44 | 2022 | |
| Stryker Corporation | $127.71 | 2022-2025 | N/A |
| Teva Pharmaceuticals USA, INC. | $50.24 | 2023-2024 | Austedo Xr |
| Acorda Therapeutics, INC | $44.69 | 2022-2024 | Inbrija |
| Pacira Pharmaceuticals Incorporated | $43.08 | 2022 | |
| Baxter Healthcare | $35.80 | 2022 | |
| Acadia Pharmaceuticals INC | $25.25 | 2024 | Nuplazid |
| Electronic Waveform Lab, INC. | $24.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.06 | 2021 | |
| Relievant Medsystems, INC. | $21.96 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Melone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.